The placenta; a multifaceted, transient organ by Burton, Graham & Fowden, Abigail
 1 
The placenta; a multifaceted, transient organ 1 
 2 
Graham J Burton and Abigail L Fowden 3 
Centre for Trophoblast Research and Department of Physiology, Development 4 
and Neuroscience, University of Cambridge 5 
 6 
 7 
Key words: placenta, fetal growth, pregnancy 8 
 9 
Address for correspondence: 10 
Professor Graham J. Burton 11 
Physiological Laboratory 12 
Downing Street 13 
Cambridge CB2 3EG 14 
Tel: +44 1223 333856 15 
Fax: +44 1223 333840 16 
E-mail: gjb2@cam.ac.uk 17 
 18 
19 
 2 
Abstract 20 
The placenta is arguably the most important organ of the body, but paradoxically 21 
the most poorly understood. During its transient existence it performs actions 22 
that are later taken on by diverse separate organs, including the lungs, liver, gut, 23 
kidneys and endocrine glands. Its principal function is to supply the fetus, and in 24 
particular the fetal brain, with oxygen and nutrients. The placenta is structurally 25 
adapted to achieve this, possessing a large surface area for exchange and a thin 26 
interhaemal membrane separating the maternal and fetal circulations. In 27 
addition, it adopts other strategies that are key to facilitating transfer, including 28 
remodelling of the maternal uterine arteries that supply the placenta to ensure 29 
optimal perfusion. Furthermore, placental hormones have profound effects on 30 
maternal metabolism, initially building up her energy reserves and then 31 
releasing these to support fetal growth in later pregnancy and lactation post-32 
natally. Bipedalism has posed unique haemodynamic challenges to the placental 33 
circulation, as pressure applied to the vena cava by the pregnant uterus may 34 
compromise venous return to the heart. These challenges, along with the 35 
immune interactions involved in maternal arterial remodelling, may explain 36 
complications of pregnancy that are almost unique to the human, including pre-37 
eclampsia. Such complications may represent a trade-off against the provision 38 
for a large fetal brain. 39 
40 
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Introduction 41 
For the nine months of its intrauterine existence the human fetus is totally 42 
reliant on the placenta, a transient extracorporeal organ that interfaces with the 43 
mother, to sustain and protect it.  This dependency is reflected in the way that 44 
various societal groups consider the placenta as a twin or guardian angel, and 45 
venerate it as a sacred object [1, 2]. Hence, the placenta is often accorded ritual 46 
burial, for in some beliefs the soul must be re-united with its placenta before 47 
being able to pass through to the afterlife. 48 
What then is the placenta? The wide variety of morphological forms seen 49 
amongst mammals makes the organ hard to define, but the comparative 50 
placentologist Harland Mossman captured the essence by stating ‘The normal 51 
mammalian placenta is an apposition or fusion of the fetal membranes to the 52 
uterine mucosa for physiological exchange’ [3].  This definition rightly recognises 53 
physiological exchange as the prime function of the placenta, but it fails to 54 
emphasise the other tasks the organ has to perform in order to achieve that 55 
function; for example, its remodelling the uterine spiral arteries in early 56 
pregnancy to establish the maternal circulation, its endocrine activity that has a 57 
profound effect on maternal metabolism, and its metabolic role in providing 58 
protected substrates for the fetus. This article provides a brief overview of the 59 
development and function of the human placenta so that its pivotal role in 60 
supporting fetal development, including the large brain, can be appreciated more 61 
fully in the context of the theory of pelvic constraint. 62 
 63 
Structure and development of the human placenta 64 
 4 
The placenta and associated extraembryonic membranes are formed from the 65 
zygote at the start of each pregnancy, and thus have the same genetic 66 
composition as the fetus.  The two principal tissue sources are the 67 
trophectoderm that forms the wall of the blastocyst, and the underlying 68 
extraembryonic mesoderm.  The trophectoderm differentiates into trophoblast, 69 
which in turn forms the epithelial covering of the placenta but also gives rise to 70 
the sub-population of invasive extravillous trophoblast cells. The 71 
extraembryonic mesoderm forms the stromal core of the placenta, from which 72 
originate the fibroblasts, vascular network and resident macrophage population.  73 
The mature placenta has been described in detail elsewhere [4, 5], but is a 74 
roughly discoid organ, on average 22 cm in diameter, 2.5 cm thick at the centre 75 
and weighing approximately 500 g. Its surfaces are the chorionic plate that faces 76 
the fetus and to which the umbilical cord is attached, and the basal plate that 77 
abuts the maternal endometrium. Between these plates is a cavity, the 78 
intervillous space, into which 30-40 elaborately branched fetal villous trees 79 
project. Each villous tree arises from a stem villus attached to the deep surface of 80 
the chorionic plate, and branches repeatedly to create a globular lobule 1-3 cm in 81 
diameter.  The centre of a lobule is located over the opening of a maternal spiral 82 
artery through the basal plate. Maternal blood released at these openings 83 
percolates between the villous branches before draining into openings of the 84 
uterine veins and exiting the placenta. Each lobule thus represents an 85 
independent maternal-fetal exchange unit.  86 
The final branches of the villous trees are the terminal villi. These present a 87 
surface area of 12-14 m2 at term, and are richly vascularised by a fetal capillary 88 
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network. The capillaries display local dilations, referred to as sinusoids, which 89 
bring the endothelium into close approximation to the covering of trophoblast. 90 
This is locally thinned and the diffusion distance between the maternal and fetal 91 
circulations may be reduced to as little at 2-3 µm. The morphological 92 
resemblance of these structures, termed vasculosyncytial membranes, to the 93 
alveoli of the lung has led to the assumption that they are the principal sites of 94 
maternal-fetal exchange. Terminal villi are formed primarily from 20 weeks of 95 
gestation onwards, and elaboration of the villous trees continues until term [6]. 96 
The epithelial covering of the villous tree is the syncytiotrophoblast, a true 97 
multinucleated syncytium that presents no intercellular clefts to the intervillous 98 
space. This arrangement may assist in preventing the vertical transmission of 99 
pathogens from the maternal blood [7], but may also facilitate regional 100 
specialisations of the syncytiotrophoblast.  Because of its location, the 101 
syncytiotrophoblast is involved in many of the functions of the placenta, such as 102 
the synthesis and secretion of large quantities of steroid and peptide hormones, 103 
protection against xenobiotics and active transport. Hence it has a high 104 
metabolic rate, and accounts for ~40% of the total oxygen consumption of the 105 
feto-placental unit [8]. Interposing such an active tissue between the maternal 106 
and fetal circulations potentially reduces the oxygen available for the fetus, and 107 
so the syncytiotrophoblast shows regional variations in thickness around the 108 
villous surface, being very thin and devoid of organelles at the site of 109 
vasculosyncytial membranes and thicker over non-vascular parts of the villous 110 
surface. Having no lateral cell boundaries may facilitate flow of the 111 
syncytioplasm, and so help to optimise oxygen supply to the fetus [9]. 112 
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The syncytiotrophoblast is a highly polarised epithelium, bearing a dense 113 
covering of microvilli on its apical border. The projections provide a surface 114 
amplification factor of 5-7x for insertion of receptor and transporter proteins. At 115 
the base of each microvillus is a clathrin-coated pit, which is capable of forming a 116 
coated vesicle for the transport of macromolecules across the 117 
syncytiotrophoblast [10].  118 
The syncytiotrophoblast is a terminally differentiated tissue, and its expansion 119 
during pregnancy is achieved by the fusion and incorporation of underlying 120 
mononuclear progenitor cytotrophoblast cells that rest on the underlying 121 
basement membrane. Fusion is a complex event that is still not fully understood, 122 
but involves exit of the progenitor from the cell cycle, the formation of gap 123 
junctions with the syncytiotrophoblast, externalisation of phosphatidylserine 124 
and the expression of two endogenous retroviral proteins that entered the 125 
primate genome 25 and >40 million years ago [11, 12].  126 
 127 
Placental transport 128 
The absence of intercellular junctions in the syncytiotrophoblast layer suggests 129 
that exchange must take place through the apical and basal plasma membranes, 130 
although there are two possible exceptions.  Firstly, the presence of water-filled 131 
transtrophoblastic channels has been postulated. The main evidence for such 132 
channels is that the human placenta is freely permeable to solutes of 1,350-5,200 133 
daltons, whereas in the epitheliochorial placenta of the sheep diffusion is 134 
restricted to molecules of <400 daltons [13, 14]. By measuring the transplacental 135 
flux of four permeants of different molecular sizes infused into patients prior to 136 
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elective caesarean section, it was concluded that pores of different sizes must 137 
exist in the human syncytiotrophoblast [15]. However, the putative channels 138 
have never been visualised in the human [16], although this lack may reflect the 139 
complexity of the syncytioplasm and the limitations of current imaging 140 
techniques. Secondly, it is well recognised that there are small, scattered defects 141 
in the syncytiotrophoblastic surface of all human placentas, leading to deposition 142 
of fibrin plaques [17, 18]. In this context the plaques represent a possible route 143 
for the diffusion of hydrophilic molecules, whereas in broader terms they may 144 
also be potential portals for the ingress of maternal immune cells and the vertical 145 
transmission of pathogens. Immunohistochemical studies have localised transfer 146 
of alphafetoprotein to these sites [19], suggesting they may play a significant role 147 
physiologically.  148 
 Exchange across the intact placental membrane can occur through three main 149 
processes; diffusion, transporter-mediated mechanisms and 150 
endocytosis/exocytosis.  151 
The rate of diffusion of an uncharged molecule is determined by Fick’s Law of 152 
diffusion, and so is proportional to the surface area for exchange, the diffusivity 153 
of the molecule in question and its concentration gradient, and inversely 154 
proportional to the diffusion distance between the circulations. Given the 155 
importance of these structural parameters, it is not unreasonable to assume that 156 
the requirements for diffusional exchange, and in particular oxygen exchange, 157 
are the principal drivers of placental architecture. Hence, the elaboration of 158 
terminal villi and vasculo-syncytial membranes as gestation advances will 159 
increase the diffusing capacity of the organ. This view is supported by the fact 160 
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that the specific theoretical diffusing capacity (ml/min/kPa/kg fetus) of the 161 
placenta for oxygen estimated stereologically remains constant across 162 
gestational age [20]. Furthermore, a reduction in the mean thickness of the 163 
villous membrane is observed in placentas from pregnancies at high altitude, 164 
enhancing the theoretical diffusing capacity [21].  165 
In addition to these structural parameters, the exchange of charged molecules 166 
will be influenced by any electrical gradient existing between the maternal and 167 
fetal circulations. In the human, a small but significant potential difference of -2.7 168 
±0.4mV fetus negative has been measured in mid-gestation [22], reducing to zero 169 
or close to it at term [23]. A potential difference also operates across the 170 
microvillous membrane of the syncytiotrophoblast, decreasing between the early 171 
(median -32 mV) and late first trimester (median -24 mV), with a small 172 
subsequent fall to term (-21 mV). These data suggest that the driving force for 173 
cation flux into the syncytiotrophoblast decreases, and that for anions increases, 174 
as pregnancy advances. 175 
Diffusion of small, relatively hydrophobic molecules, such as the respiratory 176 
gases, across the plasma membrane occurs rapidly. Hence, their flux depends 177 
more on the concentration gradient across the villous membrane rather than its 178 
surface area or thickness. The concentration gradient in turn is determined in 179 
part by maternal and environmental factors, but is predominantly influenced by 180 
the rate of blood flow across the membrane. Hence, the exchange of such 181 
molecules is referred to as being ‘flow limited’. Impairment of the uterine or 182 
umbilical circulations can therefore have a profound impact on the rate of fetal 183 
growth. By contrast, the concentration gradient for lipid insoluble (hydrophilic) 184 
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molecules, such as glucose, that do not diffuse across plasma membranes so 185 
easily is often more stable. In this case, the structural parameters of the villous 186 
membrane are more significant, and exchange is said to be ‘membrane- or 187 
diffusion-limited’.  188 
To aid the exchange of hydrophilic or charged molecules, transporter proteins 189 
may be inserted into the plasma membrane. Transporter proteins form a large 190 
and diverse family, but share common features such as substrate specificity, 191 
saturation kinetics, and the ability to be competitively inhibited [24]. 192 
Transporter proteins may simply allow exchange down a concentration gradient 193 
at a faster rate than simple diffusion alone, often referred to as facilitated 194 
diffusion. The classic example in the placenta is the GLUT family of transporters 195 
handling glucose. Alternatively, they can enable exchange of molecules, such as 196 
amino acids, against a concentration gradient, referred to as active transport, 197 
which is an energy dependent process. Expression of the genes encoding 198 
transporter proteins is in part under endocrine control, and leptin upregulates 199 
glucose and amino acid transporters, facilitating nutrient transfer [25]. In 200 
addition, one of the major benefits of transporter-mediated exchange is that 201 
under adverse conditions the rate can be modulated by altering the number of 202 
proteins inserted into the plasma membrane [26]. Thus, if the surface area for 203 
exchange is reduced experimentally in mice, or the mother is subjected to 204 
undernutrition, placental expression of certain amino acid transporters is 205 
increased, enhancing the flux [27, 28].  Full details of the signalling pathways 206 
involved are not available at present, although experimental data implicate 207 
placental Igf2 [29]. 208 
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Endocytosis is the process by which invaginations form at the apical cell surface 209 
pinch off, and then move deeper into the cytoplasm. There, they may fuse with 210 
vesicles of the lysosomal pathway, or traverse the cell and fuse with the basal 211 
surface in the process of exocytosis. The former delivers nutrients for 212 
breakdown by proteolytic enzymes molecules and use by the cell, whilst the 213 
latter represents a transport pathway. Both are active in the syncytiotrophoblast 214 
of the human placenta [30, 31]. During the first trimester a number of proteins of 215 
maternal origin accumulate in the coelomic and amniotic fluids [32], whereas 216 
later in pregnancy evidence suggests that immunoglobulin G (IgG) crosses the 217 
placenta by this mechanism [24]. Specificity and the ability to avoid lysosomal 218 
degradation during the endocytosis phase may be provided by the presence of 219 
receptors for IgG in the microvillous membrane invaginations and vesicles. 220 
 221 
Establishing the maternal placental circulation 222 
For effective transplacental exchange there must be matched perfusion in the 223 
maternal and fetal placental circulations, especially for those hydrophobic 224 
molecules whose transfer is ‘flow-limited’. Establishing the maternal circulation 225 
to a haemochorial placenta, such as the human, where the maternal-fetal 226 
interface is represented by maternal blood bathing the trophoblast surface is a 227 
major haemodynamic challenge. It requires the trophoblast to tap into branches 228 
of the maternal uterine arteries that carry blood at a higher pressure than the 229 
fetus can ever generate. Hence, there is a danger that the fetal capillaries within 230 
the terminal villi will be compressed, impeding the umbilical circulation and 231 
preventing the formation of vasculosyncytial membranes [33]. Equally, the high 232 
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velocity of maternal arterial blood flow can potentially cause mechanical damage 233 
to the delicate villous trees [34], with high shear rates also causing oxidative 234 
stress [35]. In many mammals these dangers are avoided as there is either no or 235 
only limited invasion of the maternal tissues by the trophoblast, so-called 236 
epitheliochorial and endotheliochorial placentation respectively [36]. The 237 
trophoblast is simply apposed to the uterine epithelium or the underlying 238 
stromal matrix, and the maternal blood is retained within the uterine vascular 239 
network.  240 
In all mammals, the uterine arteries undergo dilation during pregnancy in order 241 
to meet the metabolic demands of the feto-placental unit, and this is mediated by 242 
a combination of endocrine and local flow-dependent responses. In addition, in 243 
those species with a haemochorial placenta the final branches that deliver the 244 
blood to the placenta undergo considerable remodelling, resulting in their 245 
dilation as they approach the organ. In the human, data collected from pregnant 246 
hysterectomies near term indicate the diameter of the spiral arteries increases 247 
from ~0.5 mm at the endometrium/myometrium boundary to ~2.4 mm at their 248 
opening through the basal plate [37]. Mathematical modelling based on these 249 
dimensions predicts that as a consequence the velocity of maternal blood flow 250 
will reduce by an order of magnitude, from 2-3 m.s-1 to ~10 cm.s-1 [35]. 251 
The remodelling process involves the loss of smooth muscle cells from the walls 252 
of the spiral arteries, either through dedifferentiation or apoptosis, and their 253 
replacement by an inert, amorphous fibrinoid material [38, 39]. The molecular 254 
mechanisms involved are still unclear, but it is now recognised that there is an 255 
initial phase of endocrine priming followed by a second phase that is dependent 256 
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on the presence of extravillous trophoblast cells [40, 41]. Extravillous 257 
trophoblast cells are most common during the first trimester of pregnancy, and 258 
arise from the tips of anchoring villi that attach the villous trees to the 259 
endometrium. The cells proliferate and then migrate away from the placenta, 260 
either down the lumens of the spiral arteries or through the endometrial stroma. 261 
Along the latter pathway they interact with maternal immune cells, particularly 262 
the uterine Natural Killer (uNK) cells of the innate immune system.  The uNK 263 
cells accumulate in the endometrium in the late secretory phase of the non-264 
pregnant cycle, and are particularly numerous around the early implantation 265 
site.  Despite their name, uNK cells do not engage in killing the migrating 266 
trophoblast cells. Rather, it is thought that upon appropriate stimulation they 267 
release proteases and cytokines that regulate trophoblast migration and mediate 268 
the arterial remodelling [42-44]. There is a carefully orchestrated dialogue 269 
between the two cell types involving polymorphic HLA-C ligands on the 270 
trophoblast and killer-cell immunoglobulin-like receptors (KIR) on the uNK cells. 271 
Certain combinations of ligand and receptor are associated with an increase risk 272 
of complications of pregnancy, including miscarriage, pre-eclampsia and growth 273 
restriction [45].  274 
Deficient remodelling of the spiral arteries has been associated with the ‘Great 275 
Obstetrical Syndromes’ [46]. The mechanistic link is strongest in the case of pre-276 
eclampsia, when the resultant malperfusion of the placenta is thought to cause 277 
oxidative stress [47]. Oxidative stress is able to stimulate the release of 278 
proinflammatory cytokines and angiogenic regulators from the 279 
syncytiotrophoblast, which in turn leads to activation of the maternal 280 
endothelium and hence the pre-eclamptic syndrome [48, 49]. Recently, closely 281 
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related endoplasmic reticulum stress has been identified in placentas from cases 282 
of early-onset pre-eclampsia [50], and also normotensive fetal growth restriction 283 
[51]. One of the consequences of endoplasmic reticulum stress is the suppression 284 
of protein translation, which in vitro leads to a reduction in cell proliferation rate. 285 
Hence, we speculate that placental endoplasmic reticulum stress is principally 286 
causally associated with growth restriction [52], although at high levels the same 287 
pathways can also contribute to activation of pro-inflammatory responses [53]. 288 
These stresses may be exacerbated in the human by the adoption of bipedalism, 289 
for in the upright position the pregnant uterus compresses the inferior vena cava 290 
against the lordosis of the lumbar vertebral column [54].  Such compression will 291 
reduce venous return to the heart and so compromise cardiac output. In 292 
addition, it will cause venous engorgement of the intervillous space, restricting 293 
arterial inflow into the intervillous space and so potentially causing fluctuations 294 
in oxygenation. The effect is particularly marked when the mother is in the 295 
supine position [55], and fluctuations in oxygenation are a powerful stimulus for 296 
generation of placental oxidative stress [56].  297 
 298 
Development of the fetal placental vascular tree 299 
The placenta is one of the principal sites of vasculogenesis and angiogenesis, and 300 
in the space of 9 months develops a vascular network over 500 km in length. 301 
Vasculogenesis starts with the differentiation in situ of haemangioblastic clusters 302 
within the mesenchymal core of early villi during the third week post-303 
fertilisation [57]. The clusters form cords of cells, usually located immediately 304 
beneath the trophoblastic basement membrane. Indeed, it is thought that their 305 
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differentiation is induced by angiogenic growth factors secreted by the 306 
cytotrophoblast cells [58]. The cords gradually expand to form a network 307 
comprised of endothelial cells linked by tight junctions, the molecular 308 
organisation of which undergoes maturation with increasing gestational age 309 
[59]. Once a lumen is formed, haematopoietic stem cells delaminate from the 310 
inner surface of the clusters, and following further differentiation form a 311 
characteristic clump of tightly packed nucleated erythrocytes. These are not 312 
displaced until onset of the fetal placental circulation towards the end of the first 313 
trimester. The villous capillary networks undergo continued sprouting and 314 
remodelling throughout gestation [60], regulated most likely by angiogenic 315 
factors in response to changes in oxygen tension and mechanical stimuli such as 316 
shear stress and cyclic strain [57].  317 
In the absence of an autonomic nerve supply to the placenta, vasomotor control 318 
of the fetal placental circulation is regulated by the local release of factors. The 319 
muscular arteries contained within the stem villi are thought to represent the 320 
principal resistance vessels within the placenta, and the gasotransmitters nitric 321 
oxide and carbon monoxide have been implicated in modulating their vasomotor 322 
tone [61, 62]. Hydrogen sulphide has recently been demonstrated to be a potent 323 
vasodilator [63].  In this way, fetal blood flow within a lobule may be matched to 324 
maternal perfusion, ensuring maximal placental efficiency, although as yet there 325 
are no experimental data to support this suggestion. 326 
 327 
 328 
Endocrine modulation of maternal metabolism 329 
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Glucose is the principal substrate for placental and fetal metabolism, and as 330 
discussed previously it crosses the placenta by facilitated diffusion. The flux to 331 
the fetus is thus critically dependent on the concentration gradient acting across 332 
the placenta, as well as the density of transporter proteins in the trophoblastic 333 
membranes. Placental hormones modulate maternal metabolism in order to 334 
increase maternal blood glucose concentrations, and maximise transfer.  335 
The placenta is a major endocrine organ, and placental hormones have diverse 336 
profound effects on maternal physiology and behaviour [64, 65]. During early 337 
pregnancy they drive an increase in food intake and energy storage, whereas 338 
towards term they mobilise these reserves to support fetal growth and 339 
preparation for lactation [66, 67]. The most important hormones in this respect 340 
are the family of closely related placental lactogens (hPL) and placental growth 341 
hormone (hGH) (96% amino acid sequence homology). Their importance for 342 
maternal-fetal allocation of resources is exemplified by the fact that evolution of 343 
the primates was associated with considerable duplication of the genes encoding 344 
these hormones [68]. This is in marked contrast to most genes that are involved 345 
in placental evolution, which are represented by single copies that have been 346 
recruited from other developmental systems [69]. In the human, there is a gene 347 
cluster on chromosome 17 that encodes 5 growth hormone-like proteins; hGH-N 348 
encoding pituitary growth hormone, hGH-V encoding placental growth hormone, 349 
and hPL-A, hPL-B and hPL-L encoding placental lactogens.   All except hGH-N are 350 
expressed in the syncytiotrophoblast, but most circulating hPL originates from 351 
hPL-A, hPL-B.  352 
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Both progesterone and hPL are appetite stimulants, and maternal food intake 353 
increases by the end of the first trimester when the metabolic demands of the 354 
conceptus are still relatively low. The result is increased deposition of fat 355 
reserves, which represents a loss of the normal homeostatic mechanisms that 356 
regulate energy balance.  Leptin secreted by adipose tissue normally feeds back 357 
on the hypothalamus to suppress intake, but pregnancy is a state of central 358 
leptin-resistance. During pregnancy, leptin is secreted in large quantities by the 359 
syncytiotrophoblast, regulated in part through human chorionic gonadotropin 360 
and 17ß-estradiol [25]. Expression levels correlate closely with maternal serum 361 
concentrations, peaking at the end of the second and during the early third 362 
trimesters. The hormone has local effects on placental transporter expression , 363 
as well as central effects on appetite. Experimental data from rodent models 364 
indicate that placental lactogen and prolactin, secreted by the trophoblast and 365 
decidua respectively, appear to mediate the central insensitivity [70]. These 366 
hormones also stimulate beta cell proliferation in the maternal pancreas during 367 
early pregnancy, increasing insulin concentrations and so again aiding fat 368 
deposition [67]. 369 
Later in pregnancy the mother develops insulin resistance, with an 370 
accompanying increase in lipolysis and in circulating triglycerides and free fatty 371 
acids.  In the past these changes have been attributed to placental lactogen 372 
and/or prolactin, but more recent evidence casts doubt on this assumption [66]. 373 
Instead, it appears that placental growth hormone may play a more important 374 
role. Placental growth hormone is secreted tonically by the syncytiotrophoblast, 375 
unlike the pituitary form that is secreted in a pulsatile fashion. The two variants 376 
differ in only 13 amino acids out of a total of 191, and the similarity is sufficient 377 
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for the placenta to suppress maternal pituitary growth hormone production by 378 
mid-pregnancy. As its name suggests, it has strong growth promoting effects 379 
acting through GH receptors. Overexpression of the hormone in mice leads to a 380 
reduction in signalling through the insulin receptor secondary to altered 381 
expression of the p85 regulatory subunit of phosphatidyl-inositol 3-kinase [71]. 382 
Furthermore, there is a reduction in insulin-stimulated translocation of the 383 
transporter protein GLUT-4 to the plasma membrane of skeletal muscle, and a 384 
modest reduction in insulin receptors at the protein level. Collectively, these 385 
effects could explain the development of maternal insulin resistance. 386 
Placental growth hormone is also an important regulator of insulin-like growth 387 
factor 1 (IGF-1) [67, 72]. Although this protein does not cross into the fetal 388 
circulation, it does have powerful effects on fetal growth.  Maternal 389 
concentrations correlate with birth weight, and its actions are thought to be 390 
mediated through changes in maternal metabolism and nutrient partioning, 391 
stimulation of placental morphogenesis, and an increase in maternal blood flow 392 
to the placenta [26, 73].  393 
 394 
Placental metabolism 395 
Placentally-induced changes in maternal blood flow, appetite and metabolism 396 
thus ensure a plentiful supply of nutrients to the placenta. However, the placenta 397 
has its own metabolic demands, and there is a danger that as it is interposed in 398 
the maternal-fetal nutrient pathway it may preferentially deplete the supply 399 
before it reaches the fetus. Indeed, it has been estimated that the placenta 400 
consumes 40% of the oxygen supplied to the feto-placental unit, with about one 401 
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third supporting protein synthesis and another third supporting active transport 402 
and ionic pumping [8]. There are structural and metabolic aspects of the placenta 403 
that are likely to limit this potentially adverse effect. Firstly, the formation of 404 
vasculosyncytial membranes ensures that there is only a minimal amount of 405 
syncytioplasm interposed between the maternal and fetal circulations. 406 
Mitochondria and other oxygen consuming organelles, such as the endoplasmic 407 
reticulum, are generally absent from these sites, and are concentrated in thicker 408 
areas of the syncytioplasm away from the fetal capillaries. By analogy with 409 
electrical circuitry, the formation of vasculosyncytial membranes places the 410 
metabolic demands of the placenta and fetus in parallel rather than in series as 411 
would be the case if the syncytiotrophoblast layer was uniformly thick over the 412 
villous surface. 413 
Secondly, placental metabolism is heavily glycolytic even once the maternal 414 
circulation is established at the end of the first trimester [74].  Analysis of the 415 
coelomic fluid that is in communication with the placental tissues at 7-11 weeks 416 
of pregnancy showed evidence of anaerobic glycolysis, with a pH of 7.18 417 
compared to 7.38 in the maternal serum, a lactate concentration of 0.6 mmol/L 418 
compared to 0.3 mmol/L, and a base excess of -7.8 mmol/L compared to -2.6 419 
mmol/L [75]. Estimates based on placental tissues delivered at term and 420 
perfused in vitro suggest that 22% of the glucose consumed is converted to 421 
lactate even under conditions of high oxygenation [76]. Converting some of the 422 
glucose consumed to lactate rather than to carbon dioxide via the citric acid cycle 423 
may be beneficial for the fetus, for it is able to use lactate as a substrate whereas 424 
the placenta is unable to do so. In this way, the placental metabolism may be 425 
setting aside resources for the fetus.  426 
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However, there are alternative means for regenerating the NAD+ necessary for 427 
maintaining glycolysis in early placental tissues besides fermentation to lactate. 428 
The phylogenetically ancient polyol pathways are highly active in the human 429 
early placenta, and sorbitol, inositol, erythritol, mannitol and ribitol are present 430 
in the coelomic fluid in high concentrations [77]. Many of the polyol pathways 431 
are closely integrated with the pentose phosphate pathway, which is important 432 
for the synthesis of nucleotides to support rapid cell proliferation. The pentose 433 
phosphate pathway also generates NADPH, which is essential for the 434 
regeneration of reduced glutathione and proper functioning of antioxidant 435 
defences. Hence, having a ready supply of glycolytic intermediates that can be 436 
diverted down these pathways will facilitate rapid growth of the placenta whilst 437 
conferring protection against free-radical mediated damage. 438 
Although glycolysis generates only a small fraction of the ATP per glucose 439 
molecule that can be achieved through oxidative phosphorylation, it may be 440 
beneficial in situations where resources are not limiting since it relies on simpler 441 
intracellular machinery [78].  Mitochondria are energetically costly to generate 442 
and maintain, and in view of the transient nature of the placenta it may be more 443 
efficient to rely on glycolysis for much of energy production. Certainly, there is 444 
no shortage of glucose for the placental tissues during the first trimester as the 445 
endometrial secretions are carbohydrate rich and glycogen accumulates in the 446 
syncytioplasm [79, 80]. 447 
This heavy reliance on aerobic glycolysis, also referred to as Warburg 448 
metabolism, will reduce the oxygen consumption of the trophoblast compared to 449 
what it would be if oxidative phosphorylation was more prevalent. Consequently, 450 
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more oxygen is available for the fetus, along with protected resources, such as 451 
lactate. 452 
 453 
The placenta as a selective barrier 454 
The fetus requires its own unique microenvironment independent of maternal 455 
sex or stress hormones and environmental pollutants so that development of its 456 
neuroendocrine and gonadal systems is not compromised. Hence, the 457 
syncytiotrophoblast is equipped with a variety of enzymes and transporters that 458 
ensure the detoxification and efflux of xenobiotics, playing an equivalent role to 459 
hepatic cells in the adult. One of the best characterised examples is the enzyme 460 
11-ß-hydroxysteroid dehydrogenase 2 (11-ßHSD2), which oxidises maternal 461 
cortisol to the inactive metabolite cortisone. In this way, the placenta limits 462 
exposure to the potential harmful effects of maternal stress hormones, which 463 
when administered direct to the fetus cause reduced cell proliferation and 464 
growth restriction. The activity of placental 11-ßHSD2 can be perturbed through 465 
reduced mRNA expression in pathological pregnancies associated with growth 466 
restriction [81, 82], leading to hypercortisolaemia in the fetal circulation. This 467 
may impact adversely on the development of fetal organ systems, including the 468 
brain. It is notable that elevated levels of steroid hormones were recently found 469 
in the amniotic fluid of male babies who later developed autism, although 470 
whether the steroids were of maternal or fetal origin is unclear at present [83]. 471 
Sex-specific differences in placental 11-ßHSD2 activity have been reported  [84], 472 
and may potentially explain the increased risk of disorders, including autism, 473 
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arising from developmental programming in males following adverse 474 
intrauterine experiences.  475 
P-glycoprotein and members of the multidrug resistance protein (MRP) family 476 
have been localised to the apical surface of the syncytiotrophoblast and to the 477 
endothelium of the villous capillaries at term [85]. These transporters mediate 478 
the ATP-dependent efflux of a wide range of anionic organic compounds, 479 
providing protection to the fetus against exposure to potentially noxious 480 
xenobiotics.    481 
 482 
Conclusion 483 
Fetal growth can only take place at a rate commensurate with that of the delivery 484 
of nutrients and oxygen by the placenta.  There is now clear evidence that the 485 
placenta is not just a passive conduit from mother to fetus, but that it is able to 486 
respond to supply signals arising from the mother and demand signals 487 
emanating from the fetus [26, 86]. The efficiency of placental exchange is 488 
governed by a complex interplay between placental growth, transporter protein 489 
expression, rates of placental blood flow, transmembrane concentration 490 
gradients, and the metabolic demands of the placental tissues. This interplay is 491 
orchestrated by maternal, placental and fetal hormones, and under favourable 492 
conditions ensures an adequate supply to the fetus without overdepletion of 493 
maternal reserves. The relationship is best viewed as a dialogue to ensure 494 
mutual needs are met, rather than a conflict between two individuals. The 495 
haemochorial form of placentation displayed by the human provides the most 496 
intimate apposition of the maternal and fetal circulations of all the placental 497 
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types, yet the evolutionary advantages are not immediately obvious. One benefit 498 
is that it is more freely permeable to hydrophilic solutes, which are thought to 499 
pass through water-filled transtrophoblastic channels. Although the great apes 500 
also share haemochorial placentation, trophoblast invasion is deepest in the 501 
human [87]. This is consistent with the theory that greater access to the 502 
maternal blood supply facilitates growth of our large fetal brain [88]. However, 503 
the deep invasion comes at a price, for it is associated with an increased risk of 504 
complications of pregnancy, such as pre-eclampsia [89]. Recent evidence shows 505 
these complications have in part an immunological basis [45], as explored in 506 
other contributions to this issue. Adoption of the upright posture may be another 507 
contributor, for it poses unique haemodynamic challenges to the placental 508 
circulations [90]. Hence, the interactions between bipedalism and human 509 
reproduction extend beyond the issue of pelvic constraint. 510 
 511 
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